Patricio Espinosa, MD
Neuromusculoskeletal Medicine & OMM · Boca Raton, FLNPI 1861697948
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 20.4%. 2025 is the largest year on record at $72,114, more than ten times the $4,632 reported in 2019. Among neuromusculoskeletal medicine & omm clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,162 payments — averaging $113.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$50K
- Biohaven Pharmaceuticals, Inc.$30K
- Livanova USA, Inc.$28K
- EMD Serono, Inc.$27K
- Pfizer$20K
- Argenx US, Inc.$12K
- plus $77K from 54 others
Across 120 payments — averaging $9431.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$789K
- Biogen$145K
- Ipsen Pharma SAS$107K
- Argenx US, Inc.$22K
- Sanofi$16K
- EMD Serono, Inc.$13K
- plus $40K from 6 others
What the payments were for
- Consulting fees$37,50515%
- Speaking & faculty fees$135,88055%
- Travel & lodging$9,2504%
- Food & beverage$62,07225%
- Education$4000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$51,208
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$27,283
- BOTOX$20,331
- UBRELVY$19,723
- QULIPTA$13,652
- Mavenclad$9,698
- VYVGART HYTRULO$9,092
- UPLIZNA$6,986
- DYSPORT$5,783
- Gamunex-C$4,020
- Symbravo$3,713
- AUBAGIO$3,083
- ULTOMIRIS$2,627
- VYVGART$1,661
- AVEIR$1,398
- Swoop$883
- Confirm Rx$697
- ZEPOSIA$603
- TYSABRI$600
- JOT DX$580
How this compares
$245,108 in reported general payments places this provider in the 95th percentile of 41 neuromusculoskeletal medicine & omm providers in Florida.
See all neuromusculoskeletal medicine & omm providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 90 | $795,403 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 16 | $316,913 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 15 | $201,260 |
| IngrezzaValbenazine Tosylate | 20 | $171,295 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 17 | $157,787 |
| Nurtec OdtRimegepant Sulfate | 80 | $155,628 |
| EpidiolexCannabidiol (Cbd) | 16 | $146,148 |
| Kesimpta PenOfatumumab | 15 | $130,462 |
| PanzygaImmun Glob G(Igg)-Ifas/Glycine | 14 | $104,320 |
| RytaryCarbidopa/Levodopa | 54 | $71,085 |
| Emgality PenGalcanezumab-Gnlm | 44 | $34,486 |
| BotoxOnabotulinumtoxina | 24 | $31,730 |
| MounjaroTirzepatide | 26 | $26,747 |
| EliquisApixaban | 21 | $20,323 |
| BriviactBrivaracetam | 12 | $19,660 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid, Vyvanse | $1,011 | $801,184101 claims |
| PfizerOctagam, Nurtec Odt, Panzyga, Eliquis | $20,071 | $481,531130 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $780 | $171,29520 claims |
| CSL BehringPrivigen | $842 | $157,78717 claims |
| Amneal Pharmaceuticals LLCRytary | $747 | $71,08554 claims |
| AbbVieBotox, Ubrelvy, Qulipta | $49,919 | $58,92546 claims |
| Lilly USA, LLCMounjaro | $1,598 | $26,74726 claims |
| UCB, Inc.Briviact | $3,122 | $19,66012 claims |
| Corium, LLCAdlarity | $547 | $9,77121 claims |
| Johnson & JohnsonXarelto | $831 | $7,95111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 41 neuromusculoskeletal medicine & omm providers in Florida.
Other neuromusculoskeletal medicine & omm in Boca Raton
- Hassan BitarBrandon$12K
- Mohamad SalehTemple Terrace$11K
- Issachar DevineLake Mary$6K
- Ramon Lugo-SanchezMiramar$6K
- Chitto SarkarPort St Lucie$2K
- Glenn ChapmanBoynton Beach$2K
- Jesse KemmerlinSouth Miami$2K
- Jonathan QuinonezRiverview$1K
- Joel SteinFort Lauderdale$1K
- Xiawei ZhongOrlando$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.